Vol. 280, Issue 6, R1736-R1740, June 2001
Function of human intrinsic cardiac neurons in situ
Rakesh Christopher
Arora1,
Gregory Matthew
Hirsch1,
Kristine Johnson
Hirsch2,
Camille Hancock
Friesen1, and
John Andrew
Armour3
Departments of 1 Surgery,
2 Anesthesiology, and
3 Physiology and Biophysics, Dalhousie
University, Halifax, Nova Scotia, B3H 4H7, Canada
 |
ABSTRACT |
We sought
to determine the behavior of intrinsic cardiac neurons in human
subjects undergoing cardiac surgery and to correlate their activity
with hemodynamics status. A lead II electrocardiogram, pulmonary artery
pressure, and systemic arterial pressure were recorded along with
extracellular activity generated by right atrial neurons in 10 patients
undergoing coronary artery bypass surgery. Identified neurons generated
spontaneously activity that was, for the most part, unrelated to the
cardiac cycle. Most neurons were activated by gentle mechanical
distortion of ventricular epicardial loci. The activity generated by
neurons in each patient increased when arterial pressure increased and
decreased when arterial pressure fell. Intrinsic cardiac neurons
continued to generate activity during cardioplegia and cardiopulmonary
bypass, but at reduced levels. Normal neuronal activity was restored
postbypass. It is concluded that human intrinsic cardiac neurons
generate spontaneous activity and that many receive inputs from
ventricular mechanosensory neurites. The latter may account for the
fact that their behavior depends, in part, on cardiac dynamics. They
are also sensitive to intravenously administered pharmacological
agents. These data also indicate that cardiopulmonary bypass and
cardioplegia do not induce residual depression of their function.
-adrenoceptor agonist; cardiac mechanosensory neurites; cardioplegia; cardiopulmonary bypass
 |
INTRODUCTION |
MULTIPLE NEURONAL
SUBTYPES have been identified within the mammalian intrinsic
cardiac nervous system, both anatomically (4, 6, 8, 10)
and functionally (1, 2). It has been proposed that the
intrinsic cardiac nervous system is important for the maintenance of
adequate cardiac output (11), particularly in disease
states such as myocardial ischemia (2). Canine
intrinsic cardiac neurons display complex behavioral patterns that
rely, to a considerable degree, on their cardiovascular sensory inputs. These inputs, in turn, are dependent on cardiovascular status (1,
2). It is known that the human cardiac efferent nervous system
displays functional characteristics similar to those found in animals
(5, 9). It remains to be established whether neurons in
the human heart behave in a manner similar to that identified in animal
models. Furthermore, we do not know what effects cardiopulmonary bypass
(CPB) and cardioplegia have on the human intrinsic cardiac nervous system.
The present experiments were designed to determine whether human
intrinsic cardiac neurons generate spontaneous activity and, if so, how
they respond to altered cardiovascular status. Additionally, we sought
to determine whether cardiac afferent inputs to the human intrinsic
cardiac nervous system alter its behavior. Finally, we sought to
determine whether CPB and cardioplegia exert deleterious effects on
human intrinsic cardiac neuronal function.
 |
MATERIALS AND METHODS |
General methods.
Ethical approval for human experimentation at our institution is
reached through a clinical and layperson peer-reviewed process at the
Queen Elizabeth II Hospital, Halifax, Nova Scotia, Canada. Once full
ethical approval of the study was achieved, patients were approached
for entry into the study in accordance with guidelines set forth by the
Queen Elizabeth II Hospital Ethics Committee. To qualify for entry into
this study, a patient needed to have angiographic evidence of a lesion
in at least one major coronary artery that required the coronary artery
bypass grafting (CABG) procedure (Table
1). Patients were excluded from
this study if they had depressed left ventricular function, required
another procedure combined with the CABG procedure, or refused to
consent to the recording procedure. Ten patients scheduled for CABG
procedures entered this study. Basic demographic data and
comorbid variables were collected from each patient upon entry into the
study. Left ventricular ejection fractions were determined in
each patient by means of transthoracic or transesophageal
echocardiography, radionucleotide imaging, or left ventriculography
performed at time of selective coronary catheterization. Operative
variables relating to pump and aortic cross- clamp times, times to
extubation postprocedure, as well as intensive care unit and total
length of stay were assessed for each patient.
Operative procedures.
After instigation of general anesthesia, a midline sternotomy was
performed to expose the heart, and the appropriate bypass conduit
was harvested in the usual fashion for CABG. Once the pericardotomy was
completed, baseline systemic and pulmonary artery pressures were
recorded along with a two-lead (leads II and V5) electrocardiogram (ECG). Patients were heparinized and
underwent aorto-right atriocaval cannulation in case CPB compromised
hemodynamics, so that CPB could be instigated immediately.
Recording neuronal activity.
Fatty tissue on the lateral surface of the right atrium that contains
the right atrial ganglionated plexus (RAGP) (4, 6, 10) was
exposed. A tungsten recording microelectrode was employed to record the
extracellular activity generated by right atrial neurons
(7). The microelectrode had a shank diameter of 100 µm,
an exposed tip of 5 µm, and an impedance of 9-11 M
at 1,000 Hz. The electrode was held in place by a micromanipulator attached to a
variable extension arm (Octopus 1; Medtronic, Minneapolis, MN) to
stabilize its motion.
The fat on the lateral surface of the right atrium was explored with
this microelectrode from its epicardial surface and more deeply to
adjacent atrial tissue. An indifferent electrode was attached
to the adjacent mediastinum. The RAGP was chosen for investigation
because it contains one of the largest collections of intrinsic cardiac
neurons without an associated large coronary artery (4).
Thus we could explore it with an electrode without potentially injuring
a major coronary artery. The midline sternotomy permitted easy access
to this plexus and thereby minimized stimulation of mechanosensory
nerve endings located in the epicardium that could confound neuronal
activity results.
The activity generated by right atrial neurons so recorded was
amplified differentially by means of two Princeton Applied Research
(model 113) amplifiers that had band-pass filters set at 300 Hz to 10 kHz and amplification ranges of 100-500×, placed in series. The
output of these battery-driven amplifiers was led to an audio monitor
as well as an Astromed MT9500 eight-channel rectilinear chart recorder.
Action potentials generated by individual neurons with signal-to-noise
ratios greater than 3:1 were studied, with individual neural units
being identified by the amplitude and configuration of their action
potentials. Gradually moving the electrode away from an active site
reduced the amplitude of recorded action potentials without altering
their configurations. Action potentials generated by adjacent axons of
passage are of similar magnitude as the background noise. Therefore,
with these techniques and criteria, the recording microelectrode
identifies action potentials generated by neuronal somata (cell bodies)
and/or dendrites.
Intraoperative procedures.
Once an active site was identified, various loci on the exposed
epicardial surfaces of the right and left ventricles were touched
gently. The epicardial mechanical stimuli so applied were insufficient
to distort the heart and thus alter the position of the recording
electrode tip. This procedure was performed to determine whether
identified RAGP neurons received mechanosensory inputs from such
epicardial regions. Then systemic arterial pressure was reduced or
increased by ~30% after administration of nitroglycerin (50-100
µg iv boluses) or phenylephrine (50-100 µg iv boluses), respectively.
Neuronal activity and cardiovascular variables were also
monitored during the following interventions: 1) just before
instigating total CPB, 2) when the patient was on full CPB
before the aortic cross clamp was applied, 3) during
cardioplegia as ECG quiescence occurred, and 4) at the end
of the initial cardioplegia infusion before starting the first distal
coronary artery anastomosis. A combination of cold blood and
crystalloid (4:1 ratio) is employed for cardioplegia at our institution
during CPB. Once the coronary revascularization procedures had been
completed, neuronal activity and cardiovascular variables were
monitored as CPB was discontinued. Lastly, variables were monitored
during the subsequent administration of protamine hydrochloride in 0.9 sodium chloride (150-250 mg iv). This agent is routinely employed
after completion of the CABG procedure to reverse the effects of the
previously administered heparin. Protamine was administered
over 10- to 15-min periods. Monitored hemodynamic variables were
unaffected by this intervention.
Data analysis.
Cardiac variables were analyzed over 30-s periods of time before and
during peak responses elicited by each of the interventions described
above. Action potentials with signal-to-noise ratios greater than 3:1
generated within a locus of the RAGP were counted for 30-s periods of
time to establish average activity immediately before and during
maximal responses elicited by each intervention. Fluctuations in the
amplitude of action potentials generated by individual neurons varied
by <25 µV over several minutes, retaining their same configurations
over time. Action potentials recorded in a given locus with the same
configuration and amplitude were considered to be generated by the
somata and/or dendrites of a single neuron. The means (± SE) of data
recorded during control states as well as during each intervention were
calculated. ANOVA and paired t-test with Bonferroni
correction for multiple tests were employed for statistical analysis
where appropriate. A significance value of P < 0.01 was used for these determinations.
 |
RESULTS |
Patient and operative variables.
Patient demographics, comorbid variables, and medications are listed in
Table 1. The average age of patients was 62 yr, with 80% of the
patients being male. All patients had preserved left ventricular
function. All but one patient received at least two grafts that
consisted of a left internal mammary artery to the left anterior
descending artery and either a radial artery and/or a reversed
saphenous vein graft to the remaining diseased territories. Two
patients were classified as "in-house" urgent cases, having been in
the coronary care unit awaiting the CABG procedure. There were no
complications arising from the intraoperative recording procedure. No
in-hospital deaths occurred in this cohort of patients. The majority of
patients was extubated within 4-7 h postoperatively. Both in-house
urgent patients had prolonged hospital stays (17 and 18 days). One of
these urgent patients developed left lower lobe pneumonia
postoperatively. The other patient had low cardiac output
postoperatively requiring low doses of dopamine and epinephrine for
24 h. The rest of the patients had uncomplicated recoveries.
Neuronal activity.
Using the criteria mentioned above, we identified spontaneous activity
generated by two to three intrinsic cardiac neurons in each patient
before any intervention. Multiple neuronal activity was evidenced by
the different amplitudes of their recorded action potentials (Fig.
1; Table
2). The configuration and
amplitude of each identified neuronal unit did not vary over time,
allowing for comparison of changes in neuronal activity before and
after an intervention. The activity so identified was sporadic in
nature and, for the most part, not related to a specific phase of the cardiac cycle (Fig. 1). Immediately before the CPB, the activity generated by right atrial neurons in anesthetized patients averaged 59 ± 11 impulses per minute. At that time, these patients'
systemic arterial pressure was, on average, 90/56 mmHg (Table 2).

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 1.
Continuous recording of the activity generated by right atrial
neurons and cardiovascular indexes obtained before and after
administering a bolus dose of phenylephrine into the circulation
(arrow, bottom). Neuronal activity increased soon after this
occurred and before any change in recorded cardiovascular variables was
detected (note that a paper fold prevented recording partway through
the record). ECG, electrocardiogram; AP, aortic pressure; PAP,
pulmonary pressure (the same abbreviations are used in the other
figures).
|
|
View this table:
[in this window]
[in a new window]
|
Table 2.
Alterations in heart rate, pulmonary artery pressure, and aortic
pressure, as well as activity generated by right atrial neurons
recorded during various interventions
|
|
The activity generated by identified, spontaneously active neurons
increased in seven of the 10 patients when limited loci on the exposed
anterior epicardium of the right or left ventricles were touched gently
(Table 2). No responses were elicited in the other three patients when
the exposed surfaces of the two ventricles were touched. In six of
these seven patients, additional neurons were recruited when mechanical
stimuli were applied to the epicardium, as determined by the varied
configurations of the action potentials identified (Fig.
2).

View larger version (86K):
[in this window]
[in a new window]
|
Fig. 2.
Neuronal responses elicited by a gentle touch of a locus
on the left ventricular ventral epicardium (horizontal line below). A
burst of activity was generated by right atrial neurons (neural,
bottom) during application of this stimulus. Monitored
cardiovascular variables remained unchanged.
|
|
When systemic arterial pressure increased after systemic administration
of the
-adrenoceptor agonist phenylephrine, intrinsic cardiac
neuronal activity increased (Fig. 1; Table 2). This included the
recruitment of new neuronal units with different amplitudes than
identified during baseline conditions (before phenylephrine administration). In some instances, the activity generated by right
atrial neurons increased before any detectable changes in monitored
cardiovascular variables became evident (Fig. 1). In contrast, when
systemic arterial pressure was reduced by the systemic administration
of nitroglycerin, intrinsic cardiac neuronal activity decreased (Table
2).
The activity generated by intrinsic cardiac neurons remained at
control levels (57.4 ± 18.4 impulses per minute) upon instigation of CPB before the application of the aortic cross clamp and infusion of
cardioplegia. Intrinsic cardiac neurons continued to generate activity
(41.1 ± 28.6 impulses per minute) during infusion of the
cardioplegia solution (Fig.
3B). Neuronal activity
persisted when the ECG became quiescent, but at a reduced level. For
instance, during a period of prolonged cardiac standstill after the
initial cardioplegia period, right atrial neurons generated 21.0 ± 12.1 impulses per minute (P < 0.01, compared with
control values; Fig. 3C). After completing the CABGs and
weaning the patient from CPB, neurons generated activity levels that
were similar to those recorded before these interventions were
instigated (Table 2). At the end of the procedure, protamine
hydrochloride was administered into the systemic circulation to reverse
the effects of previously administered heparin. When neuronal activity
was monitored in four patients during this intervention, we observed
that this peptide enhanced the activity generated by some neurons while activating previously quiescent neurons in other instances (Fig. 4). This occurred without any alterations
in monitored cardiovascular variables being detected. No untoward
reactions were elicited after protamine administration.

View larger version (93K):
[in this window]
[in a new window]
|
Fig. 3.
A and B represent a continuous record of the
ECG, AP, and right atrial neuronal activity obtained from the beginning
of infusing cardioplegia solution until the point of ECG quiescence.
Note that neuronal activity persisted in the presence of suppressed
cardiac electrical activity (B). C: data obtained
after cardioplegia infusion had been instituted for some time, just
before the first distal anastomosis was performed.
|
|

View larger version (101K):
[in this window]
[in a new window]
|
Fig. 4.
A burst of activity was generated by right atrial neurons
soon after the administration of protamine into the circulation
commenced (arrow, bottom). Recorded cardiovascular indexes
remained unchanged.
|
|
 |
DISCUSSION |
The results obtained in these experiments demonstrate that
populations of human intrinsic cardiac neurons generate spontaneous activity in patients undergoing cardiac surgery after anesthesia is
induced and a midline sternotomy is performed. These data support those
derived from the canine model (7) in as much as, first, the activity generated by right atrial neurons was for the most part
sporadic in nature and thus unrelated to the cardiac cycle (Fig.
1). Second, as has been found in experimental animals,
populations of human intrinsic cardiac neurons receive inputs from
ventricular mechanosensory neurites. Third, cardioplegia or
CPB procedures do not appear to reduce the capacity of human intrinsic
cardiac neurons to generate spontaneous activity after their
discontinuance (Table 2). Fourth, the activity generated by human
intrinsic cardiac neurons is dependent, in part, on cardiodynamic status.
Right atrial neurons were activated in most patients when limited loci
on the ventral epicardial surfaces of either ventricle were touched
briefly (Fig. 2). Presumably, not all investigated neurons responded to
this intervention (Table 2) because not all of them received
mechanosensory inputs from the epicardial areas investigated with local
mechanical stimuli, as occurs in animal models (2, 7). The
fact that human intrinsic cardiac neurons receive cardiac
mechanosensory inputs may explain, in part, the fact that the activity
generated by many identified right atrial neurons changed in
concordance with alterations in cardiovascular status (Fig. 1). For
instance, when systemic arterial pressure increased as a consequence of
the administration of phenylephrine (representing an increase in
afterload), neuronal activity increased. Likewise, when systemic
arterial pressure decreased after systemic administration of
nitroglycerin (representing a reduction in afterload and preload),
neuronal activity decreased. These data support those derived from the
canine model, in as much as animal intrinsic cardiac neurons are known
to receive direct inputs from ventricular mechanosensory neurites and
thus are sensitive to changing cardiodynamics (2, 7). In
accord with that, most identified neurons became inactive when systemic
arterial pressure fell below 60 mmHg. Presumably, that was primarily
due to a relative reduction of cardiac mechanosensory inputs to the
intrinsic cardiac nervous system. This agrees with the fact that
neuronal activity was lowest during cardiac standstill when the ECG was quiescent.
Administering the
-adrenergic agonist phenylephrine increased right
atrial neuronal activity concomitant with increases in systemic
arterial pressure (Table 2). These neuronal responses accompanied
changes in monitored cardiovascular indexes, presumably reflecting
increased sensory inputs as well as increasing inputs arising from
central reflexes as a result of global changes in cardiovascular
status. In some patients, activation of right atrial neurons occurred
even before any detectable changes in monitored cardiovascular indexes
became evident (Fig. 1). Populations of canine intrinsic cardiac
neurons are known to be sensitive to exogenous applied
-adrenoceptor
agonists (3). Thus
-adrenoceptor agonists may directly
affect some human intrinsic cardiac neurons. Human intrinsic cardiac
neurons also proved to be sensitive to protamine (Fig. 4). The fact
that some atrial neurons were modified by this peptide is in accord
with the fact that canine intrinsic cardiac neurons are sensitive to
multiple chemicals, including peptides and amino acids
(2).
Because intrinsic cardiac neuronal activity was restored to baseline
values by the end of bypass (Table 2), cardioplegia and CPB do not
appear to adversely affect the capacity of human intrinsic cardiac
neurons to generate spontaneous activity. We have proposed that proper
functioning of the final common regulator of cardiac behavior, the
intrinsic cardiac nervous system, may be important in the maintenance
of adequate cardiac output (11). This aspect of the human
intrinsic cardiac nervous system may be relevant with respect to
modifying cardiac function in the perioperative period.
Perspectives
Human intrinsic cardiac neurons generate spontaneous activity, as
is found in animal models. Furthermore, as in the canine model, human
intrinsic cardiac neuronal activity is dependent on cardiovascular
status. Exogenously administered therapeutic agents can also modify the
neurons' behavior. These data provide a basis for the
development of novel therapy targeting the human intrinsic cardiac
nervous system in the perioperative period. The fact that intrinsic
cardiac neurons retain their function after CPB implies that the human
intrinsic cardiac nervous system can be manipulated to advantage in the
postoperative period.
 |
ACKNOWLEDGEMENTS |
The authors gratefully acknowledge the technical assistance of R. Livingston.
 |
FOOTNOTES |
This work was supported by the Medical Research Council of Canada
(MA-10122), the Nova Scotia Heart and Stroke Foundation, and the Queen
Elizabeth II Foundation.
Address for reprint requests and other correspondence: J. A. Armour, Dept. of Physiology and Biophysics, Dalhousie Univ., Halifax, Nova Scotia, B3H 4H7, Canada (E-mail:
jarmour{at}is.dal.ca).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 29 November 2000; accepted in final form 9 February 2001.
 |
REFERENCES |
1.
Ardell, JL.
Anatomy and function of mammalian intrinsic cardiac neurons.
In: Neurocardiology, edited by Armour JA,
and Ardell JL.. New York: Oxford University Press, 1994, p. 95-114.
2.
Armour, JA.
Anatomy and function of the intrathoracic neurons regulating the mammalian heart.
In: Reflex Control of the Circulation, edited by Zucker IH,
and Gilmore JP.. Boca Raton, FL: CRC, 1991, p. 1-37.
3.
Armour, JA.
Intrinsic canine cardiac neurons involved in cardiac regulation possess
1-,
2-,
1- and
2-adrenoceptors.
Can J Cardiol
13:
277-284,
1997[ISI][Medline].
4.
Armour, JA,
Murphy DA,
Yuan BX,
MacDonald S,
and
Hopkins DA.
Anatomy of the human intrinsic cardiac nervous system.
Anat Rec
297:
289-298,
1997.
5.
Carlson, MD,
Geha AS,
Hsu J,
Martin J,
Levy MN,
Jacobs G,
and
Waldo AL.
Selective stimulation of parasympathetic nerve fibers to the human sinoatrial node.
Circulation
85:
1311-1317,
1992[Abstract/Free Full Text].
6.
Davies, F,
Francis ETB,
and
King TS.
Neurological studies on the cardiac ventricles of mammals.
J Anat
86:
302-309,
1952.
7.
Gagliardi, M,
Randall WC,
Bieger D,
Wurster RD,
Hopkins DA,
and
Armour JA.
Activity of in vivo canine cardiac plexus neurons.
Am J Physiol Heart Circ Physiol
255:
H789-H800,
1988[Abstract/Free Full Text].
8.
King, TS,
and
Coakley JB.
The intrinsic nerve cells of the cardiac atria of mammals and man.
J Anat
92:
353-376,
1958.
9.
Murphy, DA,
Johnstone DE,
and
Armour JA.
Preliminary observations on the effects of stimulation of cardiac nerves in man.
Can J Physiol Pharmacol
63:
649-655,
1985[ISI][Medline].
10.
Singh, S,
Johnson PI,
Lee RE,
Orfei E,
Lonchyna VA,
Sullivan HJ,
Montoya A,
Tran H,
Wehrmacher WH,
and
Wurster RD.
Topography of cardiac ganglia in the adult human heart.
J Thorac Cardiovasc Surg
112:
943-953,
1996[Abstract/Free Full Text].
11.
Stevenson, RS,
Thompson GW,
Wilkinson M,
Murphy DA,
and
Armour JA.
Neuronal-induced augmentation of cardiac output.
Can J Cardiol
15:
1361-1366,
2000.
Am J Physiol Regul Integr Comp Physiol 280(6):R1736-R1740
0363-6119/01 $5.00
Copyright © 2001 the American Physiological Society